drugset / Trial / NCT05969119

Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache

NCT05969119

Phase 4 Completed 30 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

Postdural puncture headache (PDPH) is a major complication of neuraxial anesthesia that can occur following spinal anesthesia and with inadvertent Dural puncture during epidural anesthesia. The presence of Pyridostigmine in CSF would be expected to increase the level of acetylcholine in CSF and subsequently in the brain through inhibition of cholinesterase. The increased level of acetylcholine would produce cerebral vasoconstriction.

Timeline

Start
2023-07-25
Primary completion
2024-01-03
Completion
2024-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pyridostigmine Small molecule 60 mg Oral

Indications